Mantle Cell Lymphoma: Novel Therapeutic Strategies Using the New Generation of BTK Inhibitors

In this interactive satellite symposium held in conjunction with the 11th Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) in Houston, Texas, expert faculty discuss strategies used to select and sequence BTK inhibitor–based therapies for patients with MCL, taking into consideration newly evolving treatment approaches, guideline recommendations and recent practice-changing clinical trial data.

Share

Program Content

Activities

BTKis in MCL
Mantle Cell Lymphoma: Novel Therapeutic Strategies Using the New Generation of BTK Inhibitors
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 05, 2023

Expires: September 28, 2024

View Activity

Activities

MCL Next Gen BTKi
Mantle Cell Lymphoma: Novel Therapeutic Strategies Using the New Generation of BTK Inhibitors
Video
Congratulations: You achieved a completion on 04/09/2022

Released: October 04, 2023

Expires: October 03, 2024

View Activity

Activities

FAQs: Role of BTKis in MCL
FAQs: Current and Emerging Roles of BTK Inhibitors in MCL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 19, 2023

Expires: October 18, 2024

View Activity

Faculty

cover img faculity

Julie M. Vose, MD, MBA

Newmann M. and Milde E. Harris Professor
Chief, Hematology/Oncology
Department of Internal Medicine
University of Nebraska Medical Center
Omaha, Nebraska

cover img faculity

Brad Kahl, MD

Professor of Medicine
Washington University School of Medicine
Director Lymphoma Program
Siteman Cancer Center
St. Louis, Missouri 

Provided by

ProCE Banner

Provided by MLI Medical Learning Institute in partnership with Clinical Care Options, LLC

Supporters

Supported by educational grants from AstraZeneca, Lilly, and Merck Sharp & Dohme LLC.

AstraZeneca

Lilly

Merck Sharp & Dohme, LLC

Partners

Clinical Care Options, LLC

ProCE Banner